logo
Select company
Select metric
$ -204.78MFree Cash Flow
VS
Market
6
Sector
6
Industry
10
History
6
$ 3.77Close
$ 0.98 - $ 4.15 52-Week Range
Ticker Information

Ticker

EDIT

Company Name

EDITAS MEDICINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

EDITAS MEDICINE INC - Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EDIT - FCF Historical data
DateCapital ExpenditureFree Cash FlowNet Cash Flow - Operations
6/30/2025$ 3.42M$ -204.78M$ -201.36M
3/31/2025$ 7.07M$ -215.28M$ -208.21M
12/31/2024$ 8.83M$ -219.11M$ -210.28M
9/30/2024$ 9.59M$ -191.35M$ -181.76M
6/30/2024$ 6.91M$ -171.54M$ -164.63M
3/31/2024$ 4.75M$ -151.03M$ -146.28M
12/31/2023$ 4.72M$ -136.9M$ -132.18M
9/30/2023$ 4.04M$ -156.25M$ -152.21M
6/30/2023$ 4.41M$ -169.17M$ -164.76M
3/31/2023$ 3.69M$ -167.58M$ -163.89M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EDITAS MEDICINE INC's latest trailing twelve months (TTM) FCF stands at $ -106.11M.
  • Over the past 5 years, EDITAS MEDICINE INC's average FCF has been $ -174.75M.
  • The median FCF for EDITAS MEDICINE INC during this period was $ -174.76M
  • EDITAS MEDICINE INC reached its highest FCF over the past 5 years at $ -106.11M.
  • The lowest FCF recorded by EDITAS MEDICINE INC in the same timeframe $ -219.11M

EDITAS MEDICINE INC's FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Benchmarks
CompanyFCF
CCCC : C4 THERAPEUTICS INC $ -87.58MVYGR : VOYAGER THERAPEUTICS INC $ -115.83MFENC : FENNEC PHARMACEUTICALS INC $ -11.68MOABI : OMNIAB INC $ -32.04MSCPH : SCPHARMACEUTICALS INC $ -65.88MSPRO : SPERO THERAPEUTICS INC $ -32.33MCELU : CELULARITY INC $ -2.63MTKNO : ALPHA TEKNOVA INC $ -10.51MUTMD : UTAH MEDICAL PRODUCTS INC $ 13.8MIVVD : INVIVYD INC $ -113.26M

Definition of Free Cash Flow

[Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
CF - Operations - CapEx
(=) FCF
FCF for EDITAS MEDICINE INC is calculated as follows: CF - Operations [ $ -98.72M ] - CapEx [ $ 7.39M ]
(=) FCF [ $ -106.11M ]

EDIT - Free Cash Flow, Last 5 years

$ -219.11M

Minimum

Dec 31, 2024

$ -106.11M

Maximum

Sep 30, 2020

$ -174.75M

Average

$ -174.76M

Median

FCF Benchmark Analysis

The chart above depicts the distribution of FCF for companies in the Total Stock Market. The average FCF of the companies is $ 28.75M with a standard deviation of $ 117.92M.
The following table provides additional summary stats:
FCF in the Market:
filtered constituents3.3K
min$ -356.66M
max$ 390M
average$ 28.75M
median$ 461K
std$ 117.92M